Back
Tarsus Pharmaceuticals Vs. IGC Pharma Industry Stock Comparison
Buy
63
TARS
Tarsus Pharmaceuticals
Last Price:
51.15
Seasonality Move:
13.83%
Sell
48
IGC
IGC Pharma
Last Price:
0.39
Seasonality Move:
11.66%
Buy
63
Tarsus Pharmaceuticals (TARS)
is a Buy
Is Tarsus Pharmaceuticals a Buy, Sell or Hold?
- The current Tarsus Pharmaceuticals [TARS] share price is $51.08. The Score for TARS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- TARS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.39. The Score for IGC is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- IGC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TARS Stock Price Chart
What is Tarsus Pharmaceuticals's stock price today?
-
The Tarsus Pharmaceuticals share price today is $51.08
The current trend is moderately bullish and TARS is experiencing slight selling pressure.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IGC is experiencing slight selling pressure.
TARS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 60.34 | Buy |
| Chaikin Money Flow: | -44648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.69 - 51.23) | Buy |
| Bollinger Bands (100): | (26.8 - 45.46) | Buy |
IGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 60.57 | Buy |
| Chaikin Money Flow: | -231556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.38) | Buy |
| Bollinger Bands (100): | (0.35 - 0.41) | Buy |
TARS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.09 | Sell |
| 20-day SMA: | 49.23 | Buy |
| 50-day SMA: | 43.98 | Buy |
| 200-day SMA: | 34.45 | Buy |
| 8-day EMA: | 50.96 | Buy |
| 20-day EMA: | 49.38 | Buy |
| 50-day EMA: | 44.69 | Buy |
| 200-day EMA: | 34.71 | Buy |
IGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Buy |
| 20-day SMA: | 0.36 | Buy |
| 50-day SMA: | 0.37 | Buy |
| 200-day SMA: | 0.42 | Sell |
| 8-day EMA: | 0.37 | Buy |
| 20-day EMA: | 0.37 | Buy |
| 50-day EMA: | 0.37 | Buy |
| 200-day EMA: | 0.39 | Buy |
Tarsus Pharmaceuticals Earnings Growth & TARS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $1.55 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.11 per share.
Tarsus Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
IGC Pharma Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||